C. Kosmas

J. Syrios, E. Felekouras, E. Papalambros, 2011, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Pharmacokinetics and toxicity of an yttrium‐90‐citc‐dtpa‐hmfg1 radioimmunoconjugate for intraperitoneal radioimmunotherapy of ovarian cancer

A. Maraveyas, C. Meares, A. Epenetos, 1994 .

Pharmacokinetics and toxicity of an yttrium-90-CITC-DTPA-HMFG1 radioimmunoconjugate for intraperitoneal radioimmunotherapy of ovarian cancer.

A. Maraveyas, C. Meares, D. Snook, 1994, Cancer.

Anti-chelate antibodies after intraperitoneal yttrium-90-labeled monoclonal antibody immunoconjugates for ovarian cancer therapy.

A. Maraveyas, C. Gooden, D. Snook, 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Prognostic Factors for Survival After Breast Conserving Therapy for Stage I and II Breast Cancer. The Role of Local Recurrence

C. Kosmas, Epenetos Aa, 1995 .

Immunoglobulin light chain variable region genes in multiple myeloma

K. Stamatopoulos, C. Kosmas, 1999, Leukemia.

Cardiotoxicity of fluoropyrimidines in different schedules of administration: a prospective study

J. Syrios, N. Tsavaris, C. Kosmas, 2007, Journal of Cancer Research and Clinical Oncology.

5-fluorouracil cardiotoxicity is a rare, dose and schedule-dependent adverse event: a prospective study.

H. Kasparian, N. Tsavaris, C. Kosmas, 2005, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Second-line treatment with oxaliplatin, leucovorin and 5-fluorouracil in gemcitabine-pretreated advanced pancreatic cancer: A phase II study

E. Felekouras, E. Papalambros, N. Tsavaris, 2005, Investigational New Drugs.

Report of two cases of acute cardiac adverse events in patients with colorectal carcinoma receiving oral capecitabine

C. Kosmas, E. Koulouris, S. Lampropoulos, 2017, Anti-cancer drugs.

A simplified premedication schedule for 1-hour paclitaxel administration.

N. Tsavaris, C. Kosmas, M. Vadiaka, 2005, The journal of supportive oncology.

Extragonadal seminoma after renal transplantation and immunosuppression; treatment in the presence of renal dysfunction

N. Tsavaris, C. Kosmas, J. Boletis, 2001, Medical oncology.

Cardiotoxicity following different doses and schedules of 5-fluorouracil administration for malignancy -- a survey of 427 patients.

N. Tsavaris, C. Kosmas, M. Efremidis, 2002, Medical science monitor : international medical journal of experimental and clinical research.

Docetaxel and epirubicin supported by granulocyte colony-stimulating factor first-line in advanced breast cancer.

K. Syrigos, G. Kouraklis, H. Gogas, 2003, Anticancer research.

Monoclonal Antibody Targeting of Ovarian Carcinoma

A. Epenetos, C. Kosmas, H. Kalofonos, 1998, Oncology.

Can thromboprophylaxis build a link for cancer patients undergoing surgical and/or chemotherapy treatment? The MeTHOS cohort study

A. Pouliakis, C. Kosmas, G. Papageorgiou, 2022, Supportive Care in Cancer.

Molecular analysis of bcl‐1/IgH junctional sequences in mantle cell lymphoma: potential mechanism of the t(11;14) chromosomal translocation

K. Stamatopoulos, P. Kyriazopoulos, D. Loukopoulos, 1999, British journal of haematology.

An overview of current results with the gemcitabine and docetaxel combination as initial and salvage chemotherapy regimen in advanced non-small cell lung cancer.

N. Tsavaris, C. Kosmas, H. Kalofonos, 2003, Critical reviews in oncology/hematology.

Clonal T-large granular lymphocyte proliferations associated with clonal B cell lymphoproliferative disorders: report of eight cases

K. Stamatopoulos, T. Economopoulos, C. Kosmas, 2002, Leukemia.

Spontaneous remission of acute myeloid leukemia associated with GnRH agonist treatment

M. Siakantaris, N. Tsavaris, C. Kosmas, 2006, Leukemia & lymphoma.

t(14;18) chromosomal translocation in follicular lymphoma: an event occurring with almost equal frequency both at the D to JH and at later stages in the rearrangement process of the immunoglobulin heavy chain gene locus

K. Stamatopoulos, D. Loukopoulos, D. Anagnostou, 1997, British journal of haematology.

Targeting of tumours with murine and reshaped human monoclonal antibodies against placental alkaline phosphatase: immunolocalisation, pharmacokinetics and immune response.

H. Kalofonos, D. Snook, A. Epenetos, 1994, European journal of cancer.

9088 Phase III study of Lipoplatin plus Gemcitabine versus Cisplatin plus Gemcitabine in advanced NSCLC; interim analysis

C. Kosmas, A. Athanasiou, S. Lambaki, 2009 .

Hematopoietic stem cell mobilization strategies to support high-dose chemotherapy: A focus on relapsed/refractory germ cell tumors

C. Kosmas, Eleni Porfyriou, Sylvia Letsa, 2021, World journal of clinical oncology.

Immune Changes in Patients with Colorectal Cancer Treated by Adjuvant Therapy with Monoclonal Antibody 17-1 A: A Pilot Study

O. Tsitsilonis, E. Papalambros, N. Tsavaris, 2003, Journal of chemotherapy.

Ondansentron and Dexamethasone Treatment with Different Dosing Schedules (24 versus 32 mg) in Patients with Non-Small-Cell Lung Cancer under Cisplatin-Based Chemotherapy:A Randomized Stud y

N. Tsavaris, C. Kosmas, Konstantinos Papoutsis, 2000, Chemotherapy.

Plerixafor-aided Mobilization of Peripheral Blood Hematopoietic Stem Cells to Support Subsequent High-dose Chemotherapy After a Prior Autologous Transplant.

G. Dimitriadis, C. Kosmas, A. Grivas, 2019, Clinical lymphoma, myeloma & leukemia.

Diffuse hepatic calcinosis and hypercalcemia in association with a B‐cell (centroblastic) lymphoma

K. Stamatopoulos, I. Delladetsima, D. Loukopoulos, 1995, American journal of hematology.

Peering beneath the surface: juxtacortical tumors of bone (part II).

A. Gholamrezanezhad, C. Kosmas, Kyle Basques, 2018, Clinical imaging.

The role of humoral and cellular immunity in patients developing human anti-murine immunoglobulin antibody responses after radioimmunotherapy.

C. Kosmas, S. Man, N. Courtenay-Luck, 1990, The British journal of cancer. Supplement.

Monoclonal antibodies for imaging and therapy.

C. Kosmas, A. Epenetos, 1989, British Journal of Cancer.

Perforated appendicitis induced by pembrolizumab: a case report and review of the literature

G. Papageorgiou, C. Kosmas, C. Valavanis, 2021, Anti-cancer drugs.

Hypersensitivity Reactions to Carboplatin Administration Are Common but Not Always Severe: A 10-Year Experience

P. Sfikakis, C. Tsigris, N. Tsavaris, 2001, Oncology.

Myeloablative chemotherapy and autologous stem cell transplantation can lead to successful postengraftment mobilization of hematopoietic progenitors to support planned subsequent cycle(s) of high-dose chemotherapy and autografting in a patient with relapsed germ-cell tumor

C. Kosmas, E. Lianos, N. Gavrielatou, 2019, Anti-cancer drugs.

Analgesic activity of high-dose intravenous calcitonin in cancer patients with bone metastases.

G. Vaiopoulos, N. Tsavaris, C. Kosmas, 2006, Oncology reports.

Computed tomography-guided percutaneous biopsy for vertebral osteomyelitis: a department's experience.

M. Robbin, C. Kosmas, Vasant Garg, 2014, Neurosurgical focus.

Musculoskeletal/Radiological Manifestations of Mucolipidosis II (I-Cell disease) in late Adolescence/Early Adulthood.

A. Gholamrezanezhad, M. Robbin, D. Weinert, 2016, Pediatric endocrinology, diabetes, and metabolism.

Factors Influencing Survival in Stage IV Colorectal Cancer: The Influence of DNA Ploidy

A. Lazaris, E. Patsouris, C. Kosmas, 2013, ISRN gastroenterology.

Parameters that influence the outcome of nausea and emesis in cisplatin based chemotherapy.

P. Kosmidis, N. Tsavaris, C. Kosmas, 2000, Anticancer research.

Malignant peripheral nerve sheath tumor in neurobifromatosis type-1: two case reports

C. Kosmas, A. Karabelis, N. Mylonakis, 2009, Cases journal.

CEA and CA-19.9 Serum Tumor Markers as Prognostic Factors in Patients with Locally Advanced (Unresectable) or Metastatic Pancreatic Adenocarcinoma: A Retrospective Analysis

E. Papalambros, C. Kosmas, N. Papadoniou, 2010, Anticancer research.

Origin and diversification of the clonogenic cell in multiple myeloma: lessons from the immunoglobulin repertoire

K. Stamatopoulos, K. Zoi, P. Kollia, 2000, Leukemia.

A phase I–II study of bi-weekly gemcitabine and irinotecan as second-line chemotherapy in non-small cell lung cancer after prior taxane + platinum-based regimens

K. Syrigos, N. Tsavaris, C. Kosmas, 2006, Cancer Chemotherapy and Pharmacology.

Somatic hypermutation of immunoglobulin variable region genes: focus on follicular lymphoma and multiple myeloma

K. Stamatopoulos, D. Loukopoulos, X. Yataganas, 1998, Immunological reviews.

Analysis of the κ light chain variable region in multiple myeloma

G. Paterakis, D. Loukopoulos, P. Kollia, 1996 .

Full Dose Paclitaxel Plus Vinorelbine as Salvage Chemotherapy in Anthracycline-Resistant Advanced Breast Cancer: A Phase II Study

G. Kouraklis, G. Kouraklis, H. Gogas, 2003, Journal of chemotherapy.

Molecular insights into the immunopathogenesis of follicular lymphoma.

K. Stamatopoulos, C. Kosmas, C. Belessi, 2000, Immunology today.

Somatic hypermutation targeting to intrinsic hotspots of immunoglobulin genes in follicular lymphoma and multiple myeloma

K. Stamatopoulos, K. Zoi, C. Kosmas, 2001, Leukemia.

Molecular analysis of immunoglobulin genes in multiple myeloma.

K. Stamatopoulos, X. Yataganas, C. Kosmas, 1999, Leukemia & lymphoma.

Combined treatment with Bevacizumab and standard chemotherapy restores abnormal immune parameters in advanced colorectal cancer patients

A. Gritzapis, C. Baxevanis, I. Voutsas, 2012, Investigational New Drugs.

Immune changes in patients with advanced breast cancer undergoing chemotherapy with taxanes

N. Tsavaris, C. Kosmas, C Kosmas, 2002, British Journal of Cancer.

Anti-CD20-based therapy of B cell lymphoma: state of the art

K. Stamatopoulos, N. Tsavaris, C. Kosmas, 2002, Leukemia.

Mitomycin C and Vinblastine in Anthracycline-resistant Metastatic Breast Cancer: A Phase Ii Study

H. Kalofonos, C. Kosmas, A. Koutras, 2001, Tumori.

Factors that influence the antiemetic activity of metoclopramide to cisplatin based chemotherapy.

P. Kosmidis, N. Tsavaris, C. Kosmas, 1998, Oncology reports.

Gemcitabine and docetaxel as second‐line chemotherapy for patients with nonsmall cell lung carcinoma who fail prior paclitaxel plus platinum‐based regimens

N. Malamos, N. Tsavaris, C. Kosmas, 2001, Cancer.

Chemotherapy of non small cell lung cancer. A prospectively randomized study of cisplatin-etoposide versus cisplatin-mitomycin-vinblastine.

K. Dardoufas, T. Dosios, N. Tsavaris, 1997, Journal of chemotherapy.

A Phase II Study of the Docetaxel- Ifosfamide-Carboplatin Combination in Advanced Non-Small-Cell Lung Cancer

N. Tsavaris, C. Kosmas, A. Polyzos, 2005, Oncology.

Gemcitabine and vinorelbine as second-line therapy in non-small-cell lung cancer after prior treatment with taxane+platinum-based regimens.

N. Malamos, N. Tsavaris, C. Kosmas, 2001, European journal of cancer.

A phase I‐II study of docetaxel‐ifosfamide‐cisplatin (DIP) combination chemotherapy regimen in advanced nonsmall cell lung cancer

D. Dimitropoulos, N. Tsavaris, C. Kosmas, 2002, International journal of cancer.

A Phase II study of paclitaxel‐ifosfamide‐cisplatin combination in advanced nonsmall cell lung carcinoma

T. Dosios, N. Malamos, N. Tsavaris, 2000, Cancer.

Sequential Administration of 5-Fluorouracil (5FU)/Leucovorin (LV) Followed by Irinotecan (CPT-11) at Relapse versus CPT-11 Followed by 5-FU/LV in Advanced Colorectal Carcinoma

E. Felekouras, E. Papalambros, N. Tsavaris, 2007, Chemotherapy.

Two different schedules of irinotecan (CPT-11) in patients with advanced colorectal carcinoma relapsing after a 5-fluorouracil and leucovorin combination. A randomized study

E. Papalambros, C. Kosmas, A. Polyzos, 2003, Cancer Chemotherapy and Pharmacology.

Irinotecan (CPT-11) in Patients with Advanced Colon Carcinoma Relapsing after 5-Fluorouracil-Leucovorin Combination

E. Papalambros, N. Tsavaris, C. Kosmas, 2002, Chemotherapy.

Etoposide, Leucovorin (LV) and 5-Fluorouracil (5-FU) in 5-FU+LV Pre-Treated Patients with Advanced Colorectal Cancer

G. Kouraklis, N. Tsavaris, C. Kosmas, 2002, Journal of chemotherapy.

Leucovorin + 5-Fluorouracil plus Dipyridamole in Leucovorin + 5-Fluorouracil-Pretreated Patients with Advanced Colorectal Cancer: A Pilot Study of Three Different Dipyridamole Regimens

N. Tsavaris, C. Kosmas, A. Polyzos, 2001, Tumori.

Combined treatment with low-dose interferon plus vinblastine is associated with less toxicity than conventional interferon monotherapy in patients with metastatic renal cell carcinoma.

P. Kosmidis, D. Skarlos, N. Tsavaris, 2000, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Biochemical modulation of fluorouracil: comparison of methotrexate, folinic acid, and fluorouracil versus folinic acid and fluorouracil in advanced colorectal cancer: a randomized trial

P. Kosmidis, C. Kosmas, A. Polyzos, 1996, Cancer Chemotherapy and Pharmacology.

Successful treatment with cyclosporine of thymoma-related aplastic anemia.

D. Pectasides, C. Kosmas, G. Papaxoinis, 2007, Anticancer research.

Plerixafor added to G-CSF-supported paclitaxel-ifosfamide-cisplatin salvage chemotherapy enhances mobilization of adequate numbers of hematopoietic stem cells for subsequent autografting in hard-to-mobilize patients with relapsed/refractory germ-cell tumors: a single-center experience

G. Dimitriadis, N. Ziras, C. Gekas, 2014, Anti-cancer drugs.

Second high-dose chemotherapy intensification followed by hematopoietic stem cell transplantation applying a novel high-dose topotecan-based regimen in an adult Wilms' tumor patient: case report.

C. Kosmas, A. Karabelis, N. Mylonakis, 2011, Anti-cancer drugs.

Double high-dose chemotherapy and stem cell transplantation in adult Wilms' tumor.

C. Kosmas, A. Karabelis, N. Mylonakis, 2010, Future oncology.

Docetaxel in combination with mitoxantrone and granulocyte colony-stimulating factor as front-line chemotherapy in metastatic breast cancer: a multicenter phase II study.

S. Agelaki, V. Georgoulias, N. Malamos, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

Methotrexate-Paclitaxel-Epirubicin-Carboplatin (M-TEC) Combination Chemotherapy in Patients with Advanced Bladder Cancer: An Open Label Phase II Study

C. Alamanis, N. Tsavaris, C. Kosmas, 2005, Journal of chemotherapy.

A feasibility study of 1-h paclitaxel infusion in patients with solid tumors

J. Gogas, N. Tsavaris, C. Kosmas, 1997, Cancer Chemotherapy and Pharmacology.

Suggestions, Opinions and Recommendations for the Diagnosis, Management, Treatment and Surveillance of Lung Cancer

J. Dahabreh, S. Murray, C. Kosmas, 2011 .

Salvage chemotherapy with the gemcitabine/docetaxel combination in non-small cell lung cancer: an overview of recent phase II studies.

N. Tsavaris, C. Kosmas, H. Kalofonos, 2002, Medical science monitor : international medical journal of experimental and clinical research.

Docetaxel in combination with irinotecan (CPT-11) in platinum-resistant paclitaxel-pretreated ovarian cancer.

V. Georgoulias, C. Kosmidis, C. Kosmas, 2005, Anticancer research.

Double Biochemical Modulation of 5-Fluorouracil by Methotrexate and Folinic Acid for the Treatment of Advanced Colorectal Cancer

C. Kosmas, G. Karatzas, A. Polyzos, 1999 .

Intramedullary spinal cord metastases in breast cancer: report of four cases and review of the literature

D. Pectasides, C. Kosmas, M. Nikolaou, 2004, Journal of Neuro-Oncology.

Treatment strategies in CNS metastases

C. Kosmas, N. Mylonakis, G. Tsakonas, 2008 .

Somatic Hypermutation Patterns in Germinal Center B Cell Malignancies

K. Stamatopoulos, Nikolaos Laoutaris, A. Anagnostopoulos, 2003, Hematology.

Computed tomography-guided percutaneous biopsy for vertebral neoplasms: a department's experience and hybrid biopsy technique to improve yield.

S. Partovi, M. Robbin, C. Kosmas, 2016, Neurosurgical focus.

Evaluation of DNA ploidy in relation with established prognostic factors in patients with locally advanced (unresectable) or metastatic pancreatic adenocarcinoma: a retrospective analysis

A. Papalambros, A. Lazaris, E. Patsouris, 2009, BMC Cancer.

Peering beneath the surface: Juxtacortical tumors of bone (part I).

A. Gholamrezanezhad, C. Kosmas, Kyle Basques, 2018, Clinical imaging.

Paraneoplastic hypoglycaemia secondary to IGF-2 secretion from a metastatic gastrointestinal stromal tumour

H. Randeva, A. Grossman, C. Kosmas, 2020, Endocrine and Metabolic Science.

Diffusion-weighted imaging in musculoskeletal radiology-clinical applications and future directions.

H. von Tengg-Kobligk, K. Nikolaou, S. Partovi, 2015, Quantitative imaging in medicine and surgery.

Multidisciplinary approach for repeat musculoskeletal lesion biopsy after nondiagnostic initial sampling: A 10‐year single‐center experience

A. Bhatt, Vijaya Kosaraju, C. Kosmas, 2020, Journal of surgical oncology.

Topoisomerase I and IIα protein expression in primary colorectal cancer and recurrences following 5-fluorouracil-based adjuvant chemotherapy

A. Lazaris, N. Kavantzas, N. Tsavaris, 2008, Cancer Chemotherapy and Pharmacology.

Case Report: Combination of Olaparib With Chemotherapy in a Patient With ATM-Deficient Colorectal Cancer

G. Papageorgiou, C. Kosmas, Sergios Tsakatikas, 2021, Frontiers in Oncology.

Leptomeningeal Carcinomatosis after Major Remission to Taxane-based Front-line Therapy in Patients with Advanced Breast Cancer

N. Malamos, N. Tsavaris, C. Kosmas, 2002, Journal of Neuro-Oncology.

Follicular lymphoma immunoglobulin κ light chains are affected by the antigen selection process, but to a lesser degree than their partner heavy chains

K. Stamatopoulos, D. Loukopoulos, D. Anagnostou, 1997, British journal of haematology.

Magnetic resonance/positron emission tomography (MR/PET) oncologic applications: bone and soft tissue sarcoma.

S. Partovi, P. Ros, M. Robbin, 2014, Seminars in roentgenology.

Posterior Reversible Encephalopathy Syndrome Associated with Oxaliplatin Use for Pancreatic Adenocarcinoma

C. Kosmas, D. Symeonidis, Evridiki Mazlimoglou, 2021, Case Reports in Oncology.

Effects of phorbol esters and cytokines (interleukin-2,-4, and -6) on the proliferation and surface phenotype of Epstein-Barr virus immortalised human B lymphocytes.

C. Kosmas, N. Courtenay-Luck, A. Epenetos, 1992, Leukemia & lymphoma.

Phase II study of paclitaxel, ifosfamide, and cisplatin as second-line treatment in relapsed small-cell lung cancer.

N. Malamos, N. Tsavaris, C. Kosmas, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Expression of recombination activating genes-1 and-2 immunoglobulin heavy chain gene rearrangements in acute myeloid leukemia: evaluation of biological and clinical significance in a series of 76 uniformly treated patients and review of the literature.

K. Stamatopoulos, G. Paterakis, X. Yataganas, 2003, Haematologica.

Plerixafor mobilization of peripheral blood hematopoietic progenitors to support further high-dose chemotherapy cycles in a patient with germ-cell tumor relapsing after previous tandem high-dose chemotherapy and hematopoietic cell transplantation: report of a case

C. Kosmas, G. Dimitriadis, Pavlos Roditis, 2017, Anti-cancer drugs.

Gabapentin monotherapy for the treatment of chemotherapy-induced neuropathic pain: a pilot study.

P. Zis, N. Tsavaris, C. Kosmas, 2008, Pain medicine.

Phase I Study of Vinorelbine and Carboplatin Combination in Patients with Taxane and Anthracycline Pretreated Advanced Breast Cancer

S. Agelaki, V. Georgoulias, N. Malamos, 2002, Oncology.

Docetaxel-Ifosfamide Combination in Patients with Advanced Breast Cancer Failing Prior Anthracycline- Based Regimens: Results of a Phase I-II Study

N. Malamos, N. Tsavaris, C. Kosmas, 2007, Journal of chemotherapy.

Docetaxel–ifosfamide combination in patients with HER2-non-overexpressing advanced breast cancer failing prior anthracyclines

N. Malamos, N. Tsavaris, C. Kosmas, 2007, Investigational New Drugs.

Dose escalation of docetaxel

N. Malamos, N. Tsavaris, C. Kosmas, 2005 .

Phase I–II study of docetaxel and ifosfamide combination in patients with anthracycline pretreated advanced breast cancer

N. Malamos, N. Tsavaris, C. Kosmas, 2003, British Journal of Cancer.

A unique case of splenic marginal zone-cell lymphoma with synchronous clonal T-cell large granular lymphocyte proliferation: an immunologic, immunohistochemical and genotypic study.

K. Stamatopoulos, T. Economopoulos, C. Kosmas, 2003, Leukemia research.

Re-mobilization of hematopoietic progenitors for further autografting after prior myelo-ablative high-dose chemotherapy and autologous hematopoietic stem cell transplantation; the role of plerixafor

C. Kosmas, A. Grivas, E. Lianos, 2019, Leukemia & lymphoma.

The Natural History of Benign Bone Tumors of the Extremities in Asymptomatic Children: A Longitudinal Radiographic Study.

C. Kosmas, Raymond W. Liu, C. Collier, 2021, The Journal of bone and joint surgery. American volume.

Doxorubicin plus Ifosfamide as Salvage Treatment for Patients with Advanced Breast Cancer Refractory to Epirubicin plus Cyclophosphamide

C. Kosmas, A. Polyzos, C. Markopoulos, 2000 .

Antigen Selection of Multiple Myeloma Clonogenic B Cells as Evidenced by VH and VL Gene Mutations

K. Stamatopoulos, D. Loukopoulos, C. Kosmas, 1997 .

Clinicopathological differences and correlations between right and left colon cancer

K. Pavlakis, N. Ziras, K. Gkoumas, 2020, World journal of clinical cases.

The Effect of Acetabular Rim Recession on Anterior Acetabular Coverage

S. Nho, M. Salata, Scott R. Kling, 2015, The American journal of sports medicine.

Combination of three cytotoxic agents in small-cell lung cancer

D. Trafalis, C. Kosmas, G. Stathopoulos, 2012, Cancer Chemotherapy and Pharmacology.

A Comparative Study of Intraperitoneal Carboplatin versus Intravenous Carboplatin with Intravenous Cyclophosphamide in Both Arms as Initial Chemotherapy for Stage III Ovarian Cancer

N. Tsavaris, C. Kosmas, A. Polyzos, 1999, Oncology.

Complete regression of choroidal metastases from breast cancer after docetaxel-based systemic chemotherapy.

N. Malamos, C. Kosmas, M. Antonopoulos, 2000, Medical and pediatric oncology.

Phase II study of liposomal cisplatin (Lipoplatin) plus gemcitabine versus cisplatin plus gemcitabine as first line treatment in inoperable (stage IIIB/IV) non-small cell lung cancer.

C. Kosmas, A. Athanasiou, A. Rapti, 2010, Lung cancer.

Predictors of survival in stage IV metastatic colorectal cancer.

A. Papalambros, A. Lazaris, J. Syrios, 2010, Anticancer research.

Immunolocalisation of testicular tumours using radiolabelled monoclonal antibody to placental alkaline phosphatase.

H. Kalofonos, A. Bamias, D. Snook, 1990, The Journal of nuclear medicine and allied sciences.

Risk of severe acute hypersensitivity reactions after rapid paclitaxel infusion of less than 1-h duration

N. Tsavaris, C. Kosmas, 1998, Cancer Chemotherapy and Pharmacology.

Weekly Gemcitabine for the Treatment of Biliary Tract and Gallbladder Cancer

E. Papalambros, C. Kosmas, N. Papadoniou, 2004, Investigational New Drugs.

Paclitaxel-ifosfamide-cisplatin as salvage chemotherapy in ovarian cancer patients pretreated with platinum compounds and paclitaxel.

G. Kouraklis, H. Gogas, J. Griniatsos, 2007, Anticancer research.

Phase I study of dose-escalated paclitaxel, ifosfamide, and cisplatin (PIC) combination chemotherapy in advanced solid tumours

N. Malamos, N. Tsavaris, C. Kosmas, 2000, British Journal of Cancer.

Preliminary Evaluation of the Potential Prognostic Value of Serum Levels of Immunoglobulins (IgA, IgM, IgG, IgE) in Patients with Gastric Cancer

G. Kouraklis, G. Vaiopoulos, N. Tsavaris, 1998, International Journal of Biological Markers.

Hyaline fibromatosis syndrome: A rare case of multifocal intra-articular involvement.

C. Kosmas, R. Elliott, Navid Faraji, 2020, Clinical imaging.

High grade neuroendocrine carcinoma of the breast, first line and maintenance immunotherapy

G. Papageorgiou, C. Kosmas, H. Trihia, 2021, Anti-cancer drugs.

Chemotherapy-induced Complete Regression of Choroidal Metastases and Subsequent Isolated Leptomeningeal Carcinomatosis in Advanced Breast Cancer: A Case Report and Literature Review

N. Malamos, N. Tsavaris, C. Kosmas, 2000, Journal of Neuro-Oncology.

Intramedullary Spinal Cord Metastases in Breast Carcinoma: Report of Two Cases and Review of the Literature

N. Tsavaris, C. Kosmas, A. Gregoriou, 2002, Journal of chemotherapy.

Paclitaxel–ifosfamide–carboplatin combination chemotherapy regimen in advanced uterine and adnexal malignant mixed Mullerian tumours

G. Vorgias, N. Tsavaris, C. Kosmas, 2011, British Journal of Cancer.

Evaluation of the paclitaxel–ifosfamide–cisplatin (TIP) combination in relapsed and/or metastatic cervical cancer

N. Malamos, G. Vorgias, T. Akrivos, 2009, British Journal of Cancer.

Treatment of intermediate-grade and high-grade non-Hodgkin's lymphoma.

N. Malamos, C. Kosmas, M. Antonopoulos, 1998, The New England journal of medicine.

Absence of Somatic Hypermutation in the Open Reading Frame of the Bcl-2 Gene Participating in the t(14;18) Chromosomal Translocation in Follicular Lymphoma

K. Stamatopoulos, X. Yataganas, C. Kosmas, 2002, Leukemia & lymphoma.

Combined epirubicin, 5-fluorouracil and folinic acid vs no treatment for patients with advanced pancreatic cancer: a prospective comparative study.

N. Tsavaris, C. Kosmas, M. Tzivras, 1998, Journal of chemotherapy.

Intramedullary Spinal Cord Metastases from Atypical Small Cell Lung Cancer: A Case Report and Literature Review

C. Kosmas, M. Nikolaou, D. Pectasides, 2006, Cancer investigation.

Dual-layer spectral computerized tomography for metal artifact reduction: small versus large orthopedic devices

P. Rajiah, A. Gholamrezanezhad, C. Kosmas, 2019, Skeletal Radiology.

Advanced Lung Cancer Survival in Times of Economic Hardship: A Greek Paradigm

K. Triantafyllou, C. Kosmas, D. Theodoridis, 2020 .

Irinotecan and gemcitabine in patients with advanced non-small cell lung cancer, previously treated with cisplatin-based chemotherapy. A phase II study.

D. Farmakis, D. Pectasides, C. Kosmas, 2003, Anticancer Research.

Case report: Adenocarcinoma of the larynx with later hepatocellular differentiation

C. Kosmas, D. Symeonidis, E. Lianos, 2021, Journal of Clinical Images and Medical Case Reports.

Long-term clinical outcomes of dual-cycle radiofrequency ablation technique for treatment of osteoid osteoma

M. Robbin, C. Kosmas, S. Abboud, 2016, Skeletal Radiology.

The Effect of Acetabular Rim Recession on Anterior Acetabular Coverage: A Cadaveric Study Using the False Profile Radiograph

S. Nho, M. Salata, Scott R. Kling, 2014 .

Pegylated liposomal doxorubicin in the CHOP regimen for older patients with aggressive (stages III/IV) non-Hodgkin's lymphoma.

S. Giannouli, G. Pangalis, M. Siakantaris, 2002, Anticancer research.

Adenocarcinoma of the Colon Presenting as Polymyositis: Case Report

G. Vaiopoulos, N. Tsavaris, C. Kosmas, 2002, Journal of chemotherapy.

Subsets of patients with advanced gastric cancer responding to second-line chemotherapy with docetaxel-cisplatin.

G. Kouraklis, H. Gogas, J. Griniatsos, 2006, Anticancer research.

Liposomally-encapsulated cisplatin (Lipoplatin) plus gemcitabine in NSCLC: Preliminary results of a phase II trial and its antiangiogenesis potential

T. Boulikas, C. Kosmas, A. Athanasiou, 2008 .

A Randomized Comparative Study of Antiemetic Prophylaxis with Ondansentron in a Single 32-mg Loading Dose versus 8 mg Every 6 h in Patients Undergoing Cisplatin-Based Chemotherapy

G. Fountzilas, P. Kosmidis, C. Karakousis, 1998, Oncology.

Radiolabelled monoclonal antibodies in tumour diagnosis and therapy.

C. Kosmas, H. Kalofonos, A. Epenetos, 1990, Developments in biological standardization.

Comparison of two oral regimens for the outpatient treatment of low-risk cancer patients with chemotherapy-induced neutropenia and fever: Ciprofloxacin plus cefuroxime axetil versus ciprofloxacin plus amoxicillin/clavulanate

P. Ziakas, N. Sipsas, C. Kosmas, 2007, Scandinavian journal of infectious diseases.

Imaging of Fibromatosis

C. Kosmas, 2013 .

Diagnosis and management of parathyroid carcinoma: a state of the art review.

Claudia Coelho, J. Crane, A. Miras, 2023, Endocrine-related cancer.

Efficacy of ondansentron treatment for acute emesis with different dosing schedules 8 vs 32 mg. A randomized study.

N. Tsavaris, C. Kosmas, A. Zerai, 2001, Journal of experimental & clinical cancer research : CR.

Changes of cerebrospinal fluid tumor marker levels may predict response to treatment and survival of carcinomatous meningitis in patients with advanced breast cancer

N. Tsavaris, C. Kosmas, N. Mylonakis, 2005, Medical oncology.

Rare and aggressive metastatic, axial multifocal local epithelioid sarcoma associated with paraneoplastic granulocytosis and hypoglycaemia.

C. Kosmas, M. Kallistratos, N. Mylonakis, 2007, The Lancet. Oncology.

Single-Center Longitudinal Implementation of Lecture Series Based on the American College of Radiology Appropriateness Criteria for Emergency Medicine Provider Education.

C. Kosmas, M. Makary, Jeffrey J Farrell, 2019, Current problems in diagnostic radiology.

Comparative Study of Tropisetron with the Addition of Dexamethasone or Alprazolam in Breast Cancer Patients Receiving Adjuvant Chemotherapy with CEF (Cyclophosphamide, Epirubicin and 5-Fluorouracil)

N. Tsavaris, C. Kosmas, S. Sougioultzis, 2001, Journal of chemotherapy.

Hypertestosteronemia and Infertility from a Mediastinal Extragonadal Germ Cell Tumor.

H. Randeva, G. Kaltsas, C. Kosmas, 2017, The American journal of medicine.